Endpoint Health fetches $52m Series A

Endpoint Health Inc, a precision-firstTM therapeutics company, has secured $52 million in Series A funding.

Endpoint Health Inc, a precision-firstTM therapeutics company, has secured $52 million in Series A funding. The backers included Mayfield, Humboldt Fund, AME Cloud Ventures, Boom Capital, Alix Ventures, Yaya Capital, Wireframe Ventures, The Venture Collective, HCX Ventures and Global Health Investment Corporation.

Source: Press Release